Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

Dow Jones Top Company Headlines at 7 PM ET: Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million | Jamie ... The DNA testing company would sell for a fraction of its peak valuation of $6 ...

(Reuters) -Drugmaker Regeneron Pharmaceuticals is acquiring majority assets of bankrupt genetic testing firm 23andMe Holding for $256 million. The once-sizzling DNA-testing startup filed for ...

Kering said it appointed Pierpaolo Piccioli as the new creative director of Balenciaga as the French luxury group faces a slowdown in demand for high-end goods, coupled with its own turnaround ...

Regeneron acquires bankrupt 23andMe for $256M, taking over its DNA database and services while pledging to uphold privacy ...

Regeneron acquires bankrupt 23andMe for $256M. What this DNA data sale means for privacy, pharma, and your genetic ...

We've got all the details about who's eligible for the massive 23andMe data breach settlement and how to make a claim -- plus, who might be able to get as much as $10,000. Thomas is a native of ...

A U.S. bankruptcy judge ruled that bankrupt DNA-testing company 23andMe has the right to sell its customers’ DNA data to potential bidders. But 23andMe has no such right. In fact, it would be ...

The restructuring comes after a turbulent period at 23andMe, with a steep decline in its share price – down more than 70% this year – negative publicity surrounding a major data breach by ...

The private equity owner of Northwind Midstream is exploring a potential sale of the Permian Basin gas infrastructure operator, with any deal expected to value the company at around $2 billion ...

which has caused a steep stock-price decline and impatience at the nonprofit foundation that controls the company. Lars Fruergaard Jorgensen, who has headed the Danish pharmaceutical company for ...